Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cybercitizen Health 2001 Drives Strategic Insights That Optimize Healthcare and Pharmaceutical Marketing.


Business Editors/Health & Medical Writers

NEW YORK--(BW HealthWire)--June 27, 2001

Cyber Dialogue Announces the Annual Release of its Strategic

Consumer Intelligence Service Featuring Robust Data and Analysis of

Offline and Online Health Consumers

Cyber Dialogue, a marketing technology and services company, today announced the release of Cybercitizen(R) Health 2001 (CCH CCH Colegio de Ciencias y Humanidades (Spanish)
CCH Certified Clinical Hypnotherapist
CCH Cook County Hospital
CCH Certified in Classical Homeopathy
CCH Country Club Hills (Fairfax City, VA, USA) 
), a strategic consumer intelligence service designed to help pharmaceutical and healthcare companies improve the efficiency and impact of their marketing initiatives.

Now in its sixth year, CCH tracks consumer behavior, attitudes and demographics The attributes of people in a particular geographic area. Used for marketing purposes, population, ethnic origins, religion, spoken language, income and age range are examples of demographic data.  across topics such as the patient-physician relationship patient-physician relationship Medtalk A formal relationship that exists between the physician and the Pt, often equated to medical 'duties' that the physician must perform in a professionally acceptable manner. See Doctor-Pt interaction. Cf Abandonment. , direct-to-consumer and over-the-counter marketing over-the-counter market

Trading in stocks and bonds that does not take place on stock exchanges. Such trading occurs most often in the U.S., where requirements for listing stocks on the exchanges are strict.
, condition-specific communities and privacy. CCH subscribers also receive direct contact with Cyber Dialogue's veteran team of healthcare analysts who provide the industry expertise needed to fully take advantage of the data set.

CCH 2001 does not simply identify the "who" and the "what" of consumer health usage. Instead, CCH focuses on the "why" and "how" by identifying what drives consumers as they make health decisions, as well as locating barriers that prevent them from adopting a product or service. CCH also probes the ever-evolving interaction between patients, physicians, payors and pharmaceutical companies by tracing the trends and evolution of consumer actions and business reactions. In addition, CCH provides valuable insight into how businesses can apply technology to gain competitive advantage and improve return on investment through a marketing mix that traverses multiple media channels.

"Businesses that subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day"
subscribe, take

buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company";
 CCH receive the richest set of data on consumer attitudes and use of health-related products and services, as well as access to analysts who can shape data-driven marketing initiatives," said Thaddeus Grimes-Gruczka, vice president of Cyber Dialogue's Health Practice. "CCH is already a key strategic asset for 15 of the top 20 pharma companies, and is seen as a critical tool for identifying new audiences and markets, as well as understanding their most valuable customers."

Cybercitizen Health is based on in-depth, random-digit-dialed interviews conducted with more than 2,700 American adults. As a result of CCH's rigorous methodology and statistical strength, the data can be projected to the U.S. population as a whole, giving the subscriber accurate forecasting and market sizing capabilities. Cybercitizen Health also provides subscribers with a stream of continuous analysis through deliverables such as:
-- Analyst inquiry privileges with Cyber Dialogue's experienced health team.

-- Monthly industry reports that offer in-depth analysis, strategic guidance
and actionable recommendations on timely topics.

-- Weekly trend reports that concisely discuss salient consumer data and trends
to support marketing and budgetary decisions.

-- An annual forecast report that predicts future trends, potential markets and
changes in the online healthcare and pharmaceutical industry.

-- Client-only Web access to all written reports and data; the data set is also
available in ASCII and table format.

-- An on-site presentation by Cyber Dialogue's health team tailored to a
client's specific needs.

-- Condition supplements that pertain to a selected medical condition group
such as allergies, arthritis, depression, diabetes, HIV/AIDS, high cholesterol,
obesity and oncology.


For more information about becoming a Cybercitizen Health 2001 subscriber, please contact Scott Haiges at 212-651-7046, health@cyberdialogue.com or http://health.cyberdialogue.com.

To receive updates from Cyber Dialogue's Health Practice, subscribe to the "Health & Pharma Insight" mailing list An automated e-mail system on the Internet, which is maintained by subject matter. There are thousands of such lists that reach millions of individuals and businesses. New users generally subscribe by sending an e-mail with the word "subscribe" in it and subsequently receive all new  at: http://www.cyberdialogue.com/healthnews.

About Cyber Dialogue

Founded in 1993, Cyber Dialogue provides technology and services that optimize optimize - optimisation  CRM (Customer Relationship Management) An integrated information system that is used to plan, schedule and control the presales and postsales activities in an organization.  and marketing investments. Applying customer intelligence to drive business strategy at all customer touch points, Cyber Dialogue helps companies improve campaign effectiveness, lower the cost of acquisition and retain their most profitable customers. Cyber Dialogue's solutions combine customer intelligence software, sophisticated analytical analytical, analytic

pertaining to or emanating from analysis.


analytical control
control of confounding by analysis of the results of a trial or test.
 services and vertical industry expertise. Cyber Dialogue's clients are industry leaders in the pharmaceutical, finance, media, retail and consumer goods consumer goods

Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and
 industries.

Cyber Dialogue's Health Practice helps its health and pharmaceutical clients manage the business complexities of the industry through an in-depth understanding of consumer interaction across condition types, privacy and regulatory issues and the need for marketing ROI Marketing ROI is a related term to Return on Marketing Investment (ROMI) and is a measure of the effectiveness (see also marketing effectiveness) of various marketing activities. . Our health and pharmaceutical clients include Aventis, California HealthCare Foundation, Merck-Medco, The National Institutes of Health, Pfizer, Pharmacia and Roche Diagnostics Roche Diagnostics Division is a subsidiary of Hoffmann-La Roche which manufactures equipment and reagents for research and medical diagnostic applications. Internally, it is organized into six major business areas: Roche Applied Science, Roche Centralized Diagnostics, Roche .

Based in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
, with offices in Fairfield, CT, and London, England, Cyber Dialogue can be contacted at www.cyberdialogue.com or at 212-651-7000.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 27, 2001
Words:697
Previous Article:Bentley Pharmaceuticals Announces Research and Licensing Agreements for Intranasal Pain Management and Topical Hormone Replacement Therapy.
Next Article:Z-Tel Supports PSC Recommended Decision Regarding UNE Price Reductions in New York.
Topics:



Related Articles
IMS HEALTH and Brio Technology to Develop Next-Generation Sales Optimization Tools.
IMS HEALTH and Brio Technology to Develop Next-Generation Sales Optimization Tools.
IMS HEALTH Strategic Technologies' Hand-Held Solutions Improve the Effectiveness of More Than 10,000 Pharmaceutical Sales Professionals in North...
IMS HEALTH SIGNS WYETH LEDERLE PORTUGAL FOR PRM.
MEDICAL DATABASE MARKETS PHARMACEUTICALS INTERNATIONALLY.
IMS HEALTH and Real Software Announce Agreement to Provide MediPlus Healthcare Insights Via KnowledgeManager.
Pharmaceutical e-Marketing Initiatives Are Cost-Effective Drivers of Direct-To-Consumer Brand Conversion, Compliance and ROI.
Cyber Dialogue Partners with WebSurveyResearch.
IMS HEALTH Forecasts 9 Percent Annual Growth in 10 Leading Global Pharmaceutical Markets Through 2005.
SoftWatch Delivers New Connector to Siebel eBusiness Applications for Multichannel Pharmaceutical Marketing.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles